Harnessing the immune system using checkpoint inhibitors, CAR-T cells, and monoclonal antibodies.

Precision genome modifications targeting monogenic conditions, sickle cell, and metabolic diseases.

Investigational disease-modifying agents for Alzheimer's, Parkinson's, and ALS.

Stem cell reprogramming and tissue scaffolding for cardiac and spinal cord regeneration.

Next-generation mRNA platforms for infectious diseases and personalized neoantigen cancer vaccines.

Transcatheter valve replacements, bioresorbable stents, and novel lipid-lowering therapies.

IL-inhibitors, JAK-inhibitors, and B-cell depletors for rheumatoid arthritis and Crohn's.

Next-generation sequencing matching specific tumor mutations with targeted small molecules.

Microbial ecosystem modulation for metabolic syndrome, inflammatory bowel disease, and neuropsychiatry.

Deep learning algorithms for radiology screening, pathology grading, and acute triage.

Dual and triple incretin receptor agonists transforming diabetes, obesity, and cardiovascular risk.

Orphan drug pipelines, oligonucleotide therapeutics, and enzyme replacement therapies.